Omar Dhrif
@Omar_Vsc
Followers
280
Following
870
Media
175
Statuses
530
Tunisian #Internist & #Clinical_Immunologist @CHU_Dijon/ @eular_org @EMEUNET Social Media Sub-Committee / Interested in #Vasculitis / #ACRambassador
Tunisia
Joined July 2018
🚨Pleased to advance to #Rheumavision finals ! 👏 Congrats to all finalists, to @EMEUNET & @eular_org for this amazing event ! Really excited for the Grand Finale ➡️ So tune in🗓️June 12th at 15:45 ⏰ Hall 6 See you in #EULAR_25 Go #Team_🇫🇷 !!
🎤Get ready for the RheumaVision Grand Finale at #EULAR2025! 🔥Six finalists! Five-minute inspiring talks! And YOU get to vote for the winner! 🏆 📅 June 12, 2025 | 15:45 CEST 📍Hall 6, EULAR Congress, Fira Barcelona Watch the video here👉 https://t.co/4rxPAOr6Od
@EMEUNET
2
1
15
@Rheumatol_Int
https://t.co/ylhE7HRwW7 Full article, reading only link here !
0
0
0
💡#GCA epidemiology is fascinating 🤯 Its incidence varies inexplicably with constitutional & environmental factors🌍 ➡️Check out our latest SR-MA in @Rheumatol_Int & as we focus on seasonality & latitude influence on #GCA & how both can be connected 🔗
link.springer.com
Rheumatology International - Giant Cell Arteritis (GCA) incidence is influenced by various unexplained factors. Multiple studies have investigated seasonal influence on GCA incidence, yielding...
1
0
4
Congratulations to all #ACR2025 EMEUNET Top 10 Abstracts winners 🥳
🎉Congratulations to our winners of the #EMEUNETtop10abstracts at #ACR2025! 🌟 Danae-Mona Nöthling; Carlo Tur; @cristianasieiro @ebektasmd @daliferfreites @kensukesuga @Dr_AndreRibeiro @GunklTothLilla; Pietro Bearzi; Astrid Hofman 🌟 Stay tuned to our #EMEUNET socials 📅✨
0
0
0
It was such an incredible experience to participate in #Rheumavision. Don’t hesitate to be part of future editions !
🎥 Relive the energy of #Rheumavision – the EMEUNET competition where young rheumatologists shared insights & innovation at #EULAR_2025! 👩⚕️🧑⚕️ Watch the recap video of this inspiring event👇👇 #EULAR_2025 #EMEUNET
0
2
9
💡Pleasured to have had the chance to present our work on a national cohort with #Strokes in #GCA & #Takayasu during #SNFMI_2025 🇫🇷 🙏Thanks to @Maxime_Samson21 for mentoring this effort !
0
0
6
In case anyone is also wondering ! #EULAR2025
@Ashsunrose1 @docrota @eular_org @ACRheum Hi, in order to access any session on demand from #EULAR2025 @eular_org offers the possibility of an on demand registration, as detailed in the following post
0
0
3
Rheumatoid arthritis trt update #EULAR2025, changes are : ▶️no stratification by prognostic factors, failing csDMARD is a bad prognostic sign. ▶️Advice continue a DMARD in remission #RA @eular_org
0
1
5
💡Pr Eugenio De Miguel on utility of OGUS as a predictive factor for relapse in #GCA: 🔑Significant improvement of OGUS after treatment ➡️ Associated with the absence of relapse ⏰OGUS12LV ≤0.07 at 6 mths ➡️ 83.3% probability of relapse at 1 year #EULAR2025
0
1
13
💎New CLASS Criteria for classification of Antisynthetase syndrome 🫁 🤚 🦵 @docrota @eular_org @ACRheum
#EULAR2025
2
4
23
Pr Hatemi presenting the EULAR updates on the recommendations on management of Behçet disease with the participation of Emeunet members Omar_vsc and BettiolAle 🎉 #EULAR2025 #EMEUNET
0
2
8
🚨💡 Just found out that for #EULAR2025 you can follow & hear poster tours directly from the app wherever you are with great quality ! Again excellent from @eular_org Instructions ⬇️⬇️
0
0
5
[4/4] Maintenance📊 ⚡️RTX 500mg/6 mths (MAINRITSAN study) Initially until 18 mths then up to 48ths if📈risk of relapse : GPA/PR3/ High SCr/ENT/History of relapse/persistent ANCA+/Low Cyc exposure/IS or GC withdrawal ⚠️Underdosing & immunisation➡️ monitor ANCA & CD19
0
0
0
[3/4] GC sparing💊 💎Avocapan non inferior to GC in advocate ➡️30mg twice daily for one year ⛔️Stops GC at 4 weeks !
1
0
0
[2/4] Immunosuppressives 💉 🚨Severe organ involvement: 🥇RTX non inferior to CYC 🥈RTX preferred in most subgroups 🥉CYC & RTX combination can be preferred in severe presentation SCr > 354umol PLEX only to consider for SCr>300
1
0
1
⚡️@TerrierBen Plenary on managing GPA & MPA #ANCA vasculitis a 🧵 [1/4] GPA & MPA Induction: GC 💊 Use low dose regimen ➡️ PEXIVAS or LOVAS No strong evidence for pulses General aim is 10mg at 3 mths & 5mg at 5 mths #EULAR2025
1
2
5
Can 6 mo abatacept prevent RA long-term? @KorayTascilar
#ARIAA trial says YES. 🦠 RA developed in: 17/49 (35%) abatacept 28/49 (57%) placebo ✅ RA-free survival extended by 10 months 📌 Clinical signs (pain, TJs) predicted RA -but not MRI 📉 Protection lasted up to 5 years after
0
1
3
🚨Insightful data from @Guibree on the value of MRI in #GCA 💎18 patients pilot study ⚡️MRI was able to distinguish Arteritic from Non-Arteritic optic neuropathy in GCA 🔑Key features are Retrobulbar and Perinervous fat enhancement #EULAR2025
0
5
11
#OP0211 in #EULAR2025 Birth related factors and risk #JIA by Dr. Vilde øverlien Dåstøl🇳🇴 2Norwegian registry cohorts >1M births: 🔹 Post-term birth ➡️ lower JIA risk 🔹 Higher birth weight ➡️ lower JIA risk 🔹 Elective C-section & fall birth (girls) ➡️ higher JIA risk @eular_org
0
1
6
💡Very intresting data from Dr Eleonora Fiorini in #EGPA #EULAR2025 ⚡️Anti-PTX3 as a marker for EGPA 💎Significantly📈in EGPA vs Asthma & NP 💎Anti-PTX3 + in 35% of EGPA 💎Mostly + in ANCA - EGPA, only 9% double positivity with anti-MPO leaving only 30% seronegative pts
0
4
10
Either in #RheumaVision or in #EuroVision 🎵, @Omar_Vsc shines on the stage👨🎤 Very good presentation on the damage in immune diseases👌 #EULAR25 #EUMUNET
@EMEUNET @eular_org
0
1
7